News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,317 Results
Type
Article (8036)
Company Profile (139)
Press Release (475238)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166738)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238191)
Policy (17898)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33161)
ALS (102)
Alzheimer's disease (970)
Antibody-drug conjugate (ADC) (257)
Approvals (10349)
Artificial intelligence (313)
ASCO (159)
Autoimmune disease (198)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
BIOSECURE Act (1)
Biosimilars (104)
Biotechnology (88)
Bladder cancer (134)
Brain cancer (28)
Breast cancer (502)
Cancer (3583)
Cardiovascular disease (214)
Career advice (246)
Career pathing (1)
CAR-T (169)
Celiac Disease (1)
Cell therapy (469)
Cervical cancer (34)
Clinical research (47769)
Collaboration (1212)
Commercialization (1)
Compensation (1396)
Complete response letters (34)
COVID-19 (753)
CRISPR (63)
C-suite (720)
Cystic fibrosis (84)
Data (5533)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (337)
Diagnostics (4159)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (149)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (159)
Earnings (73099)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87493)
Executive appointments (686)
FDA (12310)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (897)
Gene editing (125)
Generative AI (9)
Gene therapy (309)
GLP-1 (286)
Government (949)
Grass and pollen (2)
Guidances (280)
Healthcare (9319)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (61)
Immunology and inflammation (98)
Immuno-oncology (55)
Indications (151)
Infectious disease (939)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (42)
IPO (12380)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (1)
Liver cancer (44)
Longevity (15)
Lung cancer (495)
Lymphoma (244)
Machine learning (27)
Management (3)
Manufacturing (515)
Marketing (7)
MASH (116)
Medical device (8641)
Medtech (8767)
Mergers & acquisitions (14360)
Metabolic disorders (693)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (213)
Neuropsychiatric disorders (38)
Neuroscience (1794)
NextGen: Class of 2026 (3153)
Non-profit (846)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (169)
Pancreatic cancer (191)
Parkinson's disease (196)
Partnered (11)
Patents (459)
Patient recruitment (484)
Peanut (31)
People (41164)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15440)
Phase 2 (21332)
Phase 3 (14363)
Pipeline (6718)
Policy (18)
Postmarket research (1572)
Preclinical (6526)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (188)
Rare diseases (558)
Real estate (3021)
Recruiting (6)
Regulatory (14724)
Reports (16)
Research institute (580)
Resumes & cover letters (46)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (150)
Series B (119)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (50)
Vaccines (312)
Venture capital (17)
Weight loss (72)
Women's health (76)
Date
Today (90)
Last 7 days (304)
Last 30 days (1170)
Last 365 days (19137)
2026 (10956)
2025 (19251)
2024 (22985)
2023 (26538)
2022 (34587)
2021 (37167)
2020 (33479)
2019 (23256)
2018 (17493)
2017 (18765)
2016 (17917)
2015 (24268)
2014 (21679)
2013 (18135)
2012 (20222)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (71)
Alaska (2)
Arizona (294)
Arkansas (11)
Asia (17851)
Australia (2090)
California (11572)
Canada (3053)
China (506)
Colorado (466)
Connecticut (395)
Delaware (205)
Europe (24574)
Florida (1726)
Georgia (364)
Hawaii (3)
Idaho (46)
Illinois (681)
India (44)
Indiana (310)
Iowa (13)
Japan (389)
Kansas (98)
Kentucky (30)
Louisiana (25)
Maine (25)
Maryland (1158)
Massachusetts (7621)
Michigan (299)
Minnesota (543)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2550)
New Mexico (12)
New York (2745)
North Carolina (1236)
North Dakota (4)
Northern California (5767)
Ohio (269)
Oklahoma (14)
Oregon (15)
Pennsylvania (2199)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4799)
Tennessee (114)
Texas (1865)
United States (37664)
Utah (347)
Vermont (1)
Virginia (147)
Washington D.C. (38)
Washington State (898)
West Virginia (1)
Wisconsin (73)
483,317 Results for "prevacus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Prevacus Announces Sale of PRV-002 to Odyssey Group International
Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced that it has entered into a definitive agreement for the sale of drug candidate PRV-002 to Odyssey Group International (OTCQB:ODYY).
February 5, 2021
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Business
Prevacus Announces Use of blinktbi’s EyeStat in Upcoming Phase 1 Clinical Study
Prevacus, Inc. announced a partnership with blinktbi, Inc for use of their patented device, EyeStat, in Prevacus’ upcoming Phase 1 clinical research study as an objective biomarker of brain function.
July 13, 2018
·
3 min read
Press Releases
Axogen, Inc. Reports Second Quarter 2026 Financial Results
July 29, 2026
·
19 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Business
Prevacus Partners with BrainScope for Upcoming Drug Study on Concussion
Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders today announced a partnership with BrainScope for use of their FDA-cleared BrainScope One device in Prevacus’ upcoming Phase 1b clinical research study as an objective biomarker of brain function
May 18, 2018
·
3 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
August 19, 2025
·
2 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
1 of 48,332
Next
